Subscribe
Magazine
Videos
Advertise
About Us
Smart Water Summit
Wastewater Summit
Drinking Water
Smart Water
Asset Management
Water Utility Management
Water Reuse
Global Thought Leaders
Podcast
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
WaterWorld Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Skye Bioscience Inc
(OP:
SKYE
)
N/A
UNCHANGED
Last Price
Updated: 3:57 PM EDT, Apr 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Skye Bioscience Inc
< Previous
1
2
Next >
Skye Bioscience And 2 Other Penny Stocks Insiders Are Buying
February 05, 2024
The Dow Jones index closed higher by more than 100 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Cannabis Stock Gainers And Losers From August 25, 2023
August 25, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Marijuana Stock Movers For August 23, 2023
August 23, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Gainers And Losers From August 24, 2023
August 24, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Skye Secures $17M And Acquires Novel Phase 2-Ready Cannabinoid 1 Receptor Inhibitor
August 21, 2023
Skye Bioscience, Inc. (OTCQB: SKYE) has undertaken a strategic initiative that expands the company's resources and technologies focused on developing therapeutic products focused on the endocannabinoid...
Via
Benzinga
Marijuana Stock Movers For August 22, 2023
August 22, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Movers For August 18, 2023
August 18, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Bearish Sentiment Across The Cannabis Space - Check Full Movers For August 21, 2023
August 21, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Bearish Monday For Marijuana Stocks - EVIO, Item 9 Labs Among Top Gainers
August 07, 2023
Via
Benzinga
Bullish Thursday For Marijuana Stocks - EVIO, Tetra Bio Pharma Among Top Gainers
August 17, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Movers For July 21, 2023
July 21, 2023
Via
Benzinga
Cannabis Stock Gainers And Losers From August 16, 2023
August 16, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Skye Completes Production Of Cannabinoid Based Drug In Preparation For Glaucoma Clinical Trial
July 06, 2023
Skye Bioscience, Inc. (OTCQB: SKYE), a pharmaceutical company developing a proprietary, synthetic cannabinoid derivative to treat glaucoma and ocular hypertension, announced that its contract...
Via
Benzinga
Cannabis Stock Gainers And Losers From August 14, 2023
August 14, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Short Volatility Alert: Skye Bioscience
April 19, 2023
On Tuesday, shares of Skye Bioscience (OTC: SKYE) experienced volatile short activity. After the activity, the stock price went up +3.03% to $0.017. The overall sentiment for SKYE has been Bullish.
Via
Benzinga
Cannabis Stock Gainers And Losers From August 11, 2023
August 11, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Ethics Committee Approves Starting Multiple Ascending Dose Arm Of Phase 1 Study Of Cannabinoid Based Drug For Treatment Of Glaucoma
March 15, 2023
Skye Bioscience, Inc.
Via
Benzinga
Marijuana Stock Movers For August 8, 2023
August 08, 2023
Via
Benzinga
Glaucoma Is The Second Leading Cause Of Blindness Globally – Skye Bioscience Appears To Be Making Rapid Progress In The Development Of Their Candidate To Treat It
March 09, 2023
Biomed company Skye Bioscience (OTCQB: SKYE) has seen positive results in its clinical research so far and is preparing for the next stage in the development of its therapy for eye disease.
Via
Benzinga
Marijuana Stock Movers For August 2, 2023
August 02, 2023
Via
Benzinga
SOL Global Reduces Principal Amount Of Credit Facility From $50M To $4.52M, Announces Management Changes
February 27, 2023
SOL Global Investments Corp. (OTCQB: SKYE) (CSE:SOL) (FSE:9SB) announced that it is up to date on all interest payments and has repaid an additional $1.0 million towards its $50 million credit facility...
Via
Benzinga
Skye Receives Positive Safety Review Of Cannabinoid Based Drug For Treatment Of Glaucoma After Second Cohort Of Phase 1 Study
February 24, 2023
Skye Bioscience, Inc. (OTCQB: SKYE), a pharmaceutical company developing a proprietary, synthetic cannabinoid derivative to treat glaucoma, has received a positive recommendation following a...
Via
Benzinga
Marijuana Stock Movers For August 1, 2023
August 01, 2023
Via
Benzinga
Skye One Step Closer To Phase 2 Clinical Trial For Cannabinoid Based Drug For Treatment Of Glaucoma
January 27, 2023
Skye Bioscience, Inc. (OTCQB: SKYE) a pharmaceutical company developing a proprietary, synthetic cannabinoid derivative to treat glaucoma, reported that its phase 2 clinical trial protocol has received...
Via
Benzinga
Skye Bioscience (OTCQB: SKYE) Heads Into 2023 As A Clinical-Stage Company After Dosing Its First Human Participants
December 22, 2022
This year has been quite busy for Skye Bioscience Inc. (OTCQB: SKYE).
Via
Benzinga
Marijuana Stock Movers For July 31, 2023
July 31, 2023
Via
Benzinga
Cannabis Stock Gainers And Losers From July 28, 2023
July 28, 2023
Via
Benzinga
Cannabis Stock Gainers And Losers From July 26, 2023
July 26, 2023
Via
Benzinga
Cannabis Stock Movers For July 24, 2023
July 24, 2023
Via
Benzinga
Cannabis Stock Movers For July 20, 2023
July 20, 2023
Via
Benzinga
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.